ATENOLOL SANDOZ (Sandoz Pty Ltd)
Product name
ATENOLOL SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
45 working days (255)
Active ingredients
atenolol
Registration type
EOI
Indication
Generic medicine
ATENOLOL SANDOZ (tablets) is now indicated for the management of:
- Cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction)
- Myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain.